Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is a company that utilizes artificial intelligence to provide predictive medical diagnostics. With its DeepView System, clinicians can make an informed decision regarding treatment options for wounds and burns, potentially improving efficiency and reducing costs. The company has seen growth in its R&D revenue and recently received significant funding from BARDA, indicating strong support for its technology. However, there are some risks, such as limited reimbursement and delays to regulatory processes, that could affect the company's growth potential. Overall, the company shows promise in its innovative approach and potential for recurring revenue through its licensing model, making it an attractive investment opportunity for investors with a long-term outlook.

Bears say

Spectral AI is facing potential downsides to their financial performance due to longer clinical and regulatory development timelines, potential setbacks in regulatory or commercial approvals, and lower uptake of their DeepView system in a commercial setting. Additionally, there is potential for upside to their financial performance if clinical and regulatory developments are faster, there are additional indications and market opportunities for their products, and they secure additional non-dilutive financing sources. However, there are currently limited OUS revenues and a change in CEO may not signal a change in strategy or timelines for the company's commercial focus.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of May 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.